EGFR and cancer: One of the most effective targeting strategies to inhibit EGFR is the use of small-molecule tyrosine kinase inhibitors such as erlotinib, which have proved to be highly selective for the EGFR tyrosine kinase, resulting in cell cycle arrest, inhibition of proliferation and apoptosis of cancer cells4, 5, 6, 7.